Dendritic cell-derived exosomes need to activate both T and B Cells to induce antitumor immunity

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2712-2719

  Näslund, Tanja I ^a   Gehrmann, Ulf ^a   Qazi, Khaleda R ^a   Karlsson, Mikael C I ^a   Gabrielsson, Susanne ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; DEXOSOME; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; B-LYMPHOCYTE SUBSETS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EXOSOMES; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SKIN NEOPLASMS;

EID: 84874903268     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203082     Document Type: Article

References (27)

1. Steinman, R. M. 2012. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30: 1-22
2. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4: 594-600
3. Luketic, L., J. Delanghe, P. T. Sobol, P. Yang, E. Frotten, K. L. Mossman, J. Gauldie, J. Bramson, and Y. Wan. 2007. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J. Immunol. 179: 5024-5032
4. Théry, C., L. Zitvogel, and S. Amigorena. 2002. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2: 569-579
5. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183: 1161-1172
6. Admyre, C., E. Telemo, N. Almqvist, J. Lötvall, R. Lahesmaa, A. Scheynius, and S. Gabrielsson. 2008. Exosomes - nanovesicles with possible roles in allergic inflammation. Allergy 63: 404-408
7. Admyre, C., J. Grunewald, J. Thyberg, S. Gripenbäck, G. Tornling, A. Eklund, A. Scheynius, and S. Gabrielsson. 2003. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur. Respir. J. 22: 578-583
8. Pisitkun, T., R. F. Shen, and M. A. Knepper. 2004. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 101: 13368-13373
9. Simpson, R. J., J. W. Lim, R. L. Moritz, and S. Mathivanan. 2009. Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 6: 267-283
10. Admyre, C., S. M. Johansson, K. R. Qazi, J. J. Filén, R. Lahesmaa, M. Norman, E. P. Neve, A. Scheynius, and S. Gabrielsson. 2007. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179: 1969-1978
11. Caby, M. P., D. Lankar, C. Vincendeau-Scherrer, G. Raposo, and C. Bonnerot. 2005. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17: 879-887
12. Morse, M. A., J. Garst, T. Osada, S. Khan, A. Hobeika, T. M. Clay, N. Valente, R. Shreeniwas, M. A. Sutton, A. Delcayre, et al. 2005. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3: 9
13. Escudier, B., T. Dorval, N. Chaput, F. André, M. P. Caby, S. Novault, C. Flament, C. Leboulaire, C. Borg, S. Amigorena, et al. 2005. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J. Transl. Med. 3: 10
14. Viaud, S., S. Ploix, V. Lapierre, C. Théry, P. H. Commere, D. Tramalloni, K. Gorrichon, P. Virault-Rocroy, T. Tursz, O. Lantz, et al. 2011. Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-g. J. Immunother. 34: 65-75
15. Qazi, K. R., U. Gehrmann, E. Domange Jordö , M. C. Karlsson, and S. Gabrielsson. 2009. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 113: 2673-2683
16. Deenick, E. K., and C. S. Ma. 2011. The regulation and role of T follicular helper cells in immunity. Immunology 134: 361-367
17. Williams, M. A., B. J. Holmes, J. C. Sun, and M. J. Bevan. 2006. Developing and maintaining protective CD8+ memory T cells. Immunol. Rev. 211: 146-153
18. Vinuesa, C. G., and J. G. Cyster. 2011. How T cells earn the follicular rite of passage. Immunity 35: 671-680
19. Cinamon, G., M. A. Zachariah, O. M. Lam, F. W. Foss, Jr., and J. G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9: 54-62
20. Makowska, A., N. N. Faizunnessa, P. Anderson, T. Midtvedt, and S. Cardell. 1999. CD1high B cells: a population of mixed origin. Eur. J. Immunol. 29: 3285-3294
21. Segura, E., S. Amigorena, and C. Théry. 2005. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol. Dis. 35: 89-93
22. DiLillo, D. J., K. Yanaba, and T. F. Tedder. 2010. B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J. Immunol. 184: 4006-4016
23. You, Y., H. Zhao, Y. Wang, and R. H. Carter. 2009. Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone. J. Immunol. 182: 7343-7347
24. Théry, C., M. Boussac, P. Véron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166: 7309-7318
25. Kelly, L. M., J. P. Pereira, T. Yi, Y. Xu, and J. G. Cyster. 2011. EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues. J. Immunol. 187: 3026-3032
26. Viaud, S., M. Terme, C. Flament, J. Taieb, F. André, S. Novault, B. Escudier, C. Robert, S. Caillat-Zucman, T. Tursz, et al. 2009. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS ONE 4: e4942
27. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9: 581-593